...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Clinical outcomes of 114 patients who underwent Gamma-knife radiosurgery for medically refractory idiopathic trigeminal neuralgia.
【24h】

Clinical outcomes of 114 patients who underwent Gamma-knife radiosurgery for medically refractory idiopathic trigeminal neuralgia.

机译:114例因难治性特发性三叉神经痛而接受伽玛刀手术的患者的临床结局。

获取原文
获取原文并翻译 | 示例
           

摘要

The optimal radiation dose and target of Gamma-knife radiosurgery (GKRS) for medically refractory idiopathic trigeminal neuralgia (TN) are contentious. We investigated the effects and trigeminal nerve deficits of GKRS using two isocenters to treat a great length of the trigeminal nerve. Between January 2005 and March 2010, 129 patients with idiopathic TN underwent GKRS at the West China Hospital of Sichuan University. A maximum central dose of 80-90 Gy was delivered to the trigeminal nerve root with two isocenters via a 4mm collimator helmet. One hundred and fourteen patients were followed-up periodically by telephone interview to determine the effects, trigeminal nerve deficits and time to the onset of pain relief. The mean follow-up duration was 29.6 months. One hundred and nine patients had complete or partial pain relief and the treatment failed in five patients. Nine patients experienced a recurrence after a mean time of 12.7 months, following an initial interval of pain relief. There were no significant differences between patients with different grades of pain relief with respect to central doses. The mean time to the onset of pain relief was 3.6 weeks. The time to the onset of complete pain relief was significantly shorter than that for partial pain relief. Forty-nine patients reported mild-to-moderate facial numbness and one patient experienced paroxysmal temporalis muscle spasms two weeks after the treatment. GKRS treatment for medically refractory idiopathic TN with two isocenters resulted in an initial pain improvement in 95.6% of patients. The early response to the treatment might suggest a good outcome but, given the high incidence of nerve deficits, GKRS for TN with two isocenters is not recommended as a routine treatment protocol.
机译:医用难治性特发性三叉神经痛(TN)的最佳伽玛刀放射剂量和目标是有争议的。我们使用两个等中心点来研究GKRS的作用和三叉神经缺损,以治疗三叉神经的较长长度。从2005年1月至2010年3月,在四川大学华西医院对129例特发性TN患者进行了GKRS。通过一个4mm的准直仪头盔将最大中心剂量80-90 Gy传递给具有两个等中心点的三叉神经根。定期通过电话采访对114例患者进行随访,以确定其效果,三叉神经缺损和缓解疼痛的时间。平均随访时间为29.6个月。一百零九名患者完全或部分缓解了疼痛,五名患者的治疗失败。在最初的缓解疼痛间隔后,平均12.7个月后有9例患者复发。在不同剂量的缓解疼痛的患者之间,就中心剂量而言没有显着差异。缓解疼痛的平均时间为3.6周。完全缓解疼痛的时间明显少于部分缓解疼痛的时间。治疗后两周,四十九名患者报告面部麻木至中度,一名患者发生阵发性颞颞肌痉挛。 GKRS治疗具有两个等中心点的难治性特发性TN可使95.6%的患者得到最初的疼痛改善。对治疗的早期反应可能表明预后良好,但鉴于神经功能缺损的发生率很高,不建议将GKRS用于具有两个等中心的TN作为常规治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号